Phage therapy is an emerging treatment for Crohn's disease, focusing on restoring balance to the gut microbiota. This method targets and eliminates specific pathogenic bacteria, potentially reducing gastrointestinal inflammation without affecting beneficial bacteria. Although still in early stages, with most research conducted on animal models, Georgian clinicians are at the forefront, applying phage therapy in clinical settings to manage Crohn's symptoms effectively.

The Eliava Institute of Phage Therapy in Tbilisi, Georgia, is a leading center in bacteriophage research and treatment. Established with a deep history in phage therapy, it specializes in combating antibiotic-resistant infections. The institute's expert team offers personalized treatment plans, utilizing phages to target specific bacterial infections, providing an alternative for patients worldwide. Additionally, Eliava plays a crucial role in educating about phage therapy's potential, promoting its integration into contemporary medicine.

This page details the specific pathologies and bacteria treatable with phage therapy, highlighting its effectiveness against antibiotic-resistant infections. Phage therapy is commonly used for skin infections, respiratory tract infections, and urinary tract infections, as well as gastrointestinal infections caused by pathogens such as E. coli. It offers a crucial alternative for patients unresponsive to traditional antibiotics, focusing on precision and safety in targeting harmful bacteria.

Phage therapy provides a targeted treatment for cystic fibrosis patients facing antibiotic-resistant lung infections. It uses bacteriophages to specifically attack pathogens like Pseudomonas aeruginosa, potentially reducing infection rates and improving lung health.

Phage therapy is increasingly recognized as a viable treatment option for osteomyelitis, a challenging bone infection often caused by bacteria resistant to conventional antibiotics. This innovative approach utilizes bacteriophages to target and eliminate the specific bacteria responsible for the infection, potentially reducing the need for prolonged antibiotic use and its associated side effects. By directly attacking the bacteria, phage therapy can facilitate better recovery outcomes, decrease the likelihood of chronic infection, and promote bone healing, making it a promising adjunct or alternative to traditional treatment methods for osteomyelitis.

Phage therapy offers a groundbreaking approach to treating bacterial infections, particularly those that are resistant to traditional antibiotics. This method utilizes bacteriophages, viruses that specifically infect and destroy bacteria, to selectively target and eliminate pathogenic bacteria while leaving beneficial bacteria unharmed. By harnessing the natural predatory capabilities of phages, this therapy can effectively combat infections in a way that reduces the risk of antibiotic resistance. Ideal for treating a variety of bacterial ailments, from skin infections to more severe systemic infections, phage therapy is gaining recognition as a vital tool in the fight against increasingly drug-resistant bacterial strains.